Tag: RAC
Race Oncology: Receives compelling preclinical breast cancer results
Race Oncology’s (RAC) preclinical research program has shown the Bisantrene treatment to be an effective chemotherapeutic agent
To test this, sixteen breast cancer...
Race Oncology: Receives $387K government tax rebate
Race Oncology (RAC) has pocketed a neat $387,000 in a tax rebate for its work in developing Bisantrene-based cancer treatments
The rebate comes...